Implant Sciences ships explosives trace detectors across five continents

Implant Sciences has shipped more than $5m of its explosives trace detectors (ETDs) across five continents in the last two months.

The shipments include a combination of QS-B220 desktop explosives and drugs trace detectors as well as QS-H150 handheld explosives trace detectors.

Implant Sciences executive vice-president Darryl Jones said: "Implant Sciences’ growth has been impressive over the past year, but more importantly, we’re seeing that it is sustainable, long-term growth.

"Our company is recognized as a true market leader in the trace detection industry, and we continue to win contracts despite significant competition in the market."

Incorporating the company’s patented non-radioactive ion mobility spectrometry (IMS) analysis technology, the QS-B220 systems perform real-time detection and identification of trace amounts of different military, commercial and homemade explosives, as well as illicit drugs.

The QS-H150 is capable of detecting trace amounts of a range of military, commercial, and homemade explosives leveraging on its ion mobility spectrometry (IMS) technology.

The trace detection systems feature a radioactive material-free design, a low-maintenance, self-calibrating, and self-clearing design and offers improved levels of operational availability.

Implant Sciences president Robert Liscouski said: "Customers evaluating ETDs are seeing the impressive value proposition of our QS-B220 and QS-H150.

"As a company, it’s our mission to provide our customers with the best detection performance in the industry while offering a solution that will not be cost-prohibitive to own and maintain."